Evaluation of Six Commercial Mid- to High-Volume Antibody and Six Point-of-Care Lateral Flow Assays for Detection of SARS-CoV-2 Antibodies-Reference-Cited by-同舟云学术

Evaluation of Six Commercial Mid- to High-Volume Antibody and Six Point-of-Care Lateral Flow Assays for Detection of SARS-CoV-2 Antibodies

Published:2020-09-22 Issue:10 Volume:58 Page:
ISSN:0095-1137
Container-title:Journal of Clinical Microbiology
language:en
Short-container-title:J Clin Microbiol

Author:

Charlton Carmen L.¹²³^ORCID,Kanji Jamil N.¹⁴,Johal Kam¹,Bailey Ashley¹,Plitt Sabrina S.⁵,MacDonald Clayton¹²,Kunst Andrea⁶,Buss Emily⁶,Burnes Laura E.¹²,Fonseca Kevin¹⁷,Berenger Byron M.¹⁸,Schnabl Kareena²⁶,Hu Jia⁹¹⁰,Stokes William¹¹,Zelyas Nathan¹²,Tipples Graham¹³¹²

Affiliation:

1. Public Health Laboratory, Alberta Precision Laboratories, Alberta, Canada

2. Department of Laboratory Medicine and Pathology, University of Alberta, Edmonton, Alberta, Canada

3. Li Ka Shing Institute of Virology, University of Alberta, Alberta, Canada

4. Division of Infectious Diseases, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada

5. Centre for Communicable Diseases and Infection Control, Public Health Agency of Canada, Ottawa, Ontario, Canada

6. Special Chemistry Laboratory, Alberta Precision Laboratories, Edmonton, Alberta, Canada

7. Department of Microbiology, Immunology and Infectious Disease, University of Calgary, Calgary, Alberta, Canada

8. Department of Pathology and Laboratory Medicine, University of Calgary, Calgary, Alberta, Canada

9. Department of Community Health Sciences, University of Calgary, Calgary, Alberta, Canada

10. Alberta Health Services, Calgary, Alberta, Canada

11. Department of Medicine, University of Calgary, Calgary, Alberta, Canada

12. Department of Medical Microbiology and Immunology, University of Alberta, Edmonton, Canada

Abstract

Coronavirus disease (COVID) serological tests are essential to determine the overall seroprevalence of a population and to facilitate exposure estimates within that population. We performed a head-to-head assessment of enzyme immunoassays (EIAs) and point-of-care lateral flow assays (POCTs) to detect severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies. Demographics, symptoms, comorbidities, treatment, and mortality of patients whose sera were used were also reviewed. Six EIAs (Abbott, Affinity, Bio-Rad, DiaSorin, Euroimmun, and Roche) and six POCTs (BTNX, Biolidics, Deep Blue, Genrui, Getein BioTech, and Innovita) were evaluated for the detection of SARS-CoV-2 antibodies in known COVID-19-infected individuals.

Publisher

American Society for Microbiology

Subject

Microbiology (medical)

Link

https://journals.asm.org/doi/pdf/10.1128/JCM.01361-20

Reference15 articles.

1. A Novel Coronavirus Emerging in China — Key Questions for Impact Assessment

2. Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia

3. World Health Organization. 2020. Coronavirus disease (COVID-19) situation report 163. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200701-covid-19-sitrep-163.pdf?sfvrsn=c202f05b_2.

4. Laboratory Diagnosis of COVID-19: Current Issues and Challenges

5. Hanson KE Azar MM Banerjee R Chou A Colgrove RC Ginocchio CC Hayden MK Holodiny M Jain S Koo S Levy J Timbrook TT Caliendo AM Diagnostics Committee of the Infectious Diseases Society of America (IDSA). 2020. Infectious Diseases Society of America guidelines on the diagnosis of COVID-19. IDSA. www.idsociety.org/COVID19guidelines/dx.

Cited by 90 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular and serological testing in the setting of a global pandemic;Diagnostic Molecular Pathology;2024

2. Faradaic Impedimetric Immunosensor for Label-Free Point-of-Care Detection of COVID-19 Antibodies Using Gold-Interdigitated Electrode Array;Biosensors;2023-12-22

3. COVID-19: Impact, Diagnosis, Management and Phytoremediation;Current Traditional Medicine;2023-12

4. Sensitivities of a Rapid Test Versus an ELISA Kit for Detecting Anti-SARS-CoV-2 IgM/IgG in Sera from an Egyptian Cohort;Current Microbiology;2023-11-30

5. Two‐phase Bayesian latent class analysis to assess diagnostic test performance in the absence of a gold standard: COVID‐19 serological assays as a proof of concept;Vox Sanguinis;2023-10-18